series-a
Stage
2017
Founded
1
Investors
About
Sibylla Biotech is a drug discovery company that develops small molecule degraders for previously undruggable protein targets. It utilizes a proprietary computational platform called Pharmacological Protein Inactivation by Tethering (PhPIT).
Explore Sibylla Biotech's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.